State of Wisconsin Investment Board
INZY

State of Wisconsin Investment Board’s Inozyme Pharma INZY Stock Holding History

State of Wisconsin Investment Board’s Portfolio INZY Stock Details INZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-37,700
Closed -$39.6K – 2563
2022
Q4 		$39.6K Sell
37,700
-11,100
-23% -$19.4K ﹤0.01% 2415
2022
Q3 		$131K Sell
48,800
-20,100
-29% -$72.7K ﹤0.01% 2487
2022
Q2 		$329K Buy
+68,900
New +$300K ﹤0.01% 2283
2021
Q2 		– Sell
-11,400
Closed -$226K – 2114
2021
Q1 		$226K Hold
11,400
– – ﹤0.01% 1985
2020
Q4 		$235K Buy
+11,400
New +$272K ﹤0.01% 1928

Other funds holding INZY

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State of Wisconsin Investment Board's INZY Position: Q1 2023 in Review

State of Wisconsin Investment Board sold out of Inozyme Pharma (INZY) in Q1 2023, closing a stake of 37,700 shares — an estimated $39.6K sold.

State of Wisconsin Investment Board first reported a position in INZY in Q4 2020 and held it in 5 quarters. The position peaked at $329K in Q2 2022. 49 funds tracked by Wall St. Rank hold INZY as of Q1 2023.

  • State of Wisconsin Investment Board reported no remaining Inozyme Pharma position as of Q1 2023 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 37,700 Inozyme Pharma shares in Q1 2023, an estimated $39.6K.
  • State of Wisconsin Investment Board first reported a position in Inozyme Pharma in Q4 2020 and held it in 5 quarters.
  • State of Wisconsin Investment Board's Inozyme Pharma position peaked at $329K in Q2 2022.
  • 49 funds tracked by Wall St. Rank held Inozyme Pharma as of Q1 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2023, filed 15 May 2023.